Use of serum fibroblast growth factor 23 vs. plasma B-type natriuretic peptide levels in assessing the pathophysiology of patients with heart failure

Use of serum fibroblast growth factor 23 vs. plasma B-type natriuretic peptide levels in assessing the pathophysiology of patients with heart failure Hypertension Research 40, 181 (February 2017). doi:10.1038/hr.2016.130 Authors: Miki Imazu, Hiroyuki Takahama, Makoto Amaki, Yasuo Sugano, Takahiro Ohara, Takuya Hasegawa, Hideaki Kanzaki, Toshihisa Anzai, Naoki Mochizuki, Hiroshi Asanuma, Masanori Asakura & Masafumi Kitakaze
Source: Hypertension Research - Category: Cardiology Authors: Tags: B-type natriuretic peptide cardiovascular hemodynamics fibroblast growth factor 23 left-sided heart failure right-sided heart failure Source Type: research